Evome Medical Technologies, Inc. (LNDZF) Financial Statements
Evome Medical Technologies, Inc. (LNDZF) files with the U.S. Securities and Exchange Commission under CIK 0001617765. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2023
- Revenue
- 62.63 million CAD
- Net Income
- -15.60 million CAD
- Total Assets
- 48.26 million CAD
- Net Cash from Operations
- -918.91 thousand CAD
Fiscal year ended Dec 31, 2023. Latest periodic SEC filing: Apr 16, 2024. Source: SEC filings (EDGAR XBRL). Amounts in CAD.
Open the full financial statements for LNDZF in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History